Scholarly Index
Joyce F. Liu
Dana-Farber Cancer Institute; 18,319 total citations; 291 total publications; best world rank #28
Dana-Farber Cancer Institute
18,319Total citations
291Total publications
60H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Reproductive Medicine | Lifetime | 210 | US 104 | 98.84 |
| Oncology | Lifetime | 940 | US 502 | 97.90 |
| Reproductive Medicine | 2021-2025 | 29 | US 7 | 99.43 |
| Oncology | 2021-2025 | 225 | US 96 | 98.11 |
| Obstetrics and Gynecology | 2021-2025 | 247 | US 83 | 89.92 |
| Ovarian cancer diagnosis and treatment | Lifetime | 191 | US 109 | 99.03 |
| PARP inhibition in cancer therapy | Lifetime | 110 | US 55 | 98.33 |
| Cancer Mechanisms and Therapy | Lifetime | 301 | US 141 | 96.88 |
| BRCA gene mutations in cancer | Lifetime | 521 | US 274 | 96.60 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 915 | US 370 | 96.20 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 887 | US 324 | 91.24 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 28 | US 9 | 99.42 |
| PARP inhibition in cancer therapy | 2021-2025 | 31 | US 13 | 99.03 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 153 | US 37 | 97.25 |
| BRCA gene mutations in cancer | 2021-2025 | 201 | US 93 | 93.56 |
| Renal and related cancers | 2021-2025 | 587 | US 229 | 86.11 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 492 | US 113 | 81.14 |
| Cancer Mechanisms and Therapy | 2021-2025 | 608 | US 78 | 77.77 |